Pharmaceutical - Asia-Pacific, Research

Filter

Current filters:

Asia-PacificResearch

Popular Filters

1 to 25 of 146 results

Greater brand-drug adoption fuels Asia-Pacific breast cancer market

09-05-2014

Due to an increasing uptake of branded drugs in Asia-Pacific (APAC), the region’s breast cancer therapeutics…

afatinibAsia-PacificBoehringer IngelheimEisaiHalavenKadcylaMarkets & MarketingneratinibOncologypalbociclibPerjetaPfizerPharmaceuticalResearchRoche

India urged to take action on unregulated tuberculosis drug sales

23-03-2014

Although cases of tuberculosis are dropping in Europe, as is the incidence in the USA, an extremely slower…

Antibiotics and Infectious diseasesAsia-PacificHealthcareIndiaPharmaceuticalResearch

Sanofi Pasteur inks deal with Korea’s SK Chemical on vaccines

Sanofi Pasteur inks deal with Korea’s SK Chemical on vaccines

19-03-2014

In a second collaboration in less than a month, Sanofi Pasteur, the vaccines division of French drug…

Asia-PacificLicensingPharmaceuticalResearchSanofiSanofi PasteurSK ChemicalVaccines

Takeda files for diabetes drug trelagliptin succinate approval in Japan

Takeda files for diabetes drug trelagliptin succinate approval in Japan

09-03-2014

Takeda Pharmaceutical, Japan’s largest drugmaker, has submitted a New Drug Application to the Japanese…

Asia-PacificBlopressCardio-vascularDiabetesJapanPharmaceuticalRegulationResearchTakeda Pharmaceuticalstrelagliptin

AstraZeneca to establish cancer research program with Korea’s HIDI

AstraZeneca to establish cancer research program with Korea’s HIDI

07-03-2014

Anglo-Swedish pharma major AstraZeneca has signed a memorandum of understanding (MoU) with the South…

Asia-PacificAstraZenecaOncologyPharmaceuticalResearch

India now making moves into pharma innovation

India now making moves into pharma innovation

03-03-2014

In what must be seen as a significant change in focus, India is now seeing a surge of innovative research…

Asia-PacificBiosimilarsIndiaMarkets & MarketingPharmaceuticalResearch

Australian patients benefit from PBS changes; cancer research

27-02-2014

New medicines for glaucoma, diabetes and advanced soft tissue sarcoma have been approved for listing…

Asia-PacificAustraliaDiabetesFinancialHealthcareKombiglyzeOncologyPharmaceuticalResearchTrajentaVotrient

2014 to be transition year for Japan pharma

2014 to be transition year for Japan pharma

11-02-2014

2014 will be marked as a transition year for the Japanese Pharma industry – but the year is bound to…

Asia-PacificPharmaceuticalPricingRegulationResearch

Hisamitsu announces positive Phase II results for Parkinson’s disease drug

10-02-2014

Japanese drugmaker Hisamitsu Pharmaceutical’s has announced the results of a Phase II clinical study…

Asia-PacificHisamitsu PharmaLevodopaNeurologicalPharmaceuticalResearch

Regulatory update on Indian clinical research approval timelines

04-02-2014

The Drug Controller General of India (DCGI) has provided written confirmation to the pharmaceutical industry…

Asia-PacificIndiaPharmaceuticalRegulationResearch

Sagent Pharma sets up research center in China

04-02-2014

US specialty drug firm Sagent Pharmaceuticals (Nasdaq: SGNT), which has a specific emphasis on the injectable…

Asia-PacificChinaPharmaceuticalResearchSagent Pharmaceuticals

Ferrer links with Ildong and Ergomed for lorediplon development

03-02-2014

Privately-held Spanish drugmaker Ferrer has executed two agreements, one with South Korea’s Ildong…

Asia-PacificErgomed Clinical ResearchFerrer InternacionalIldong PharmaLicensinglorediplonNeurologicalPharmaceuticalResearch

AstraZeneca in licensing deal for MALT1 inhibitors; closes Bangalore R&D site

AstraZeneca in licensing deal for MALT1 inhibitors; closes Bangalore R&D site

31-01-2014

Belgium-based VIB, a non-profit research institute in life sciences, and the Center for Drug Design and…

Asia-PacificAstraZenecaIndiaInflammatory diseasesOncologyPharmaceuticalResearchTropical diseases

India loses its attraction for pharma clinical trials, as domestic regulations tighten

India loses its attraction for pharma clinical trials, as domestic regulations tighten

27-01-2014

Considered a global clinical trial hub three years ago, India has suffered a series of setbacks, with…

Asia-PacificBioconIndiaPharmaceuticalPiramal HealthcareRegulationResearch

Astellas and UMN update on Ph III trials of flu vaccine ASP7374; debuts Irribow OD in Japan

Astellas and UMN update on Ph III trials of flu vaccine ASP7374; debuts Irribow OD in Japan

15-01-2014

Japanese drug major Astellas Pharma and partner UMN Pharma have announced promising summary results for…

Asia-PacificASP7374Astellas PharmaGastro-intestinalsIrribowMarkets & MarketingPharmaceuticalResearchUMN PharmaVaccines

Takeda's vedolizumab enters Ph III in Japan for UC and Crohn's disease

Takeda's vedolizumab enters Ph III in Japan for UC and Crohn's disease

08-01-2014

Japan’s largest drugmaker Takeda Pharmaceutical revealed today that vedolizumab), an investigational…

Asia-PacificGastro-intestinalsPharmaceuticalResearchTakeda Pharmaceuticalsvedolizumab

US global share of biomedical research spending declines, as Asia gains

02-01-2014

The USA’s global share of biomedical research spending fell from 51% in 2007 to 45% in 2012, while…

Asia-PacificChinaFinancialNorth AmericaPharmaceuticalRegulationResearchUSA

Report 5: Growth strategies in Japan’s pharma market - Research & Development – by P Reed Maurer

Report 5: Growth strategies in Japan’s pharma market - Research & Development – by P Reed Maurer

06-12-2013

From the end of World War II until 1973, pharmaceutical patents in Japan were granted for processes rather…

Asia-PacificPatentsPharmaceuticalResearch

MRCF invests in Australian antibiotics start-up Auspherix

03-12-2013

Auspherix Pty, an early stage anti-infectives company developing novel antibiotics to treat resistant…

Antibiotics and Infectious diseasesAsia-PacificAuspherixAustraliaFinancialPharmaceuticalResearch

Eisai’s R&D organization undergoes “transformation”

Eisai’s R&D organization undergoes “transformation”

30-11-2013

Japanese drugmaker Eisai's president and chief executive, Haruo Naito, says that the company's R&D organization,…

Asia-PacificEisaiEuropeManagementNorth AmericaPharmaceuticalResearchUSA

India and China to lead modest growth in Asia-Pacific ophthalmology drug market

India and China to lead modest growth in Asia-Pacific ophthalmology drug market

22-11-2013

The ophthalmology therapeutics market for dry eye syndromeand glaucoma in four Asia-Pacificcountries…

Asia-PacificMarkets & MarketingOphthalmicsPharmaceuticalResearch

Australia’s TGA streamlines adverse event reporting

21-11-2013

Australia’s medicines regulator the Therapeutic Goods Administration (TGA) has introduced a streamlined…

Asia-PacificPharmaceuticalRegulationResearch

Vietnam Ministry of Health and Quintiles collaborate to advance clinical trial excellence

Vietnam Ministry of Health and Quintiles collaborate to advance clinical trial excellence

20-11-2013

The Vietnam Ministry of Health’s Administration of Science, Technology and Training has signed an agreement…

Asia-PacificPharmaceuticalQuintilesResearch

Daiichi Sankyo's edoxaban shows comparable efficacy to warfarin in Phase III trial

Daiichi Sankyo's edoxaban shows comparable efficacy to warfarin in Phase III trial

20-11-2013

Japanese drug major Daiichi Sankyo (TYO: 4568) says that its blood thinner edoxaban met the primary efficacy…

Asia-PacificCardio-vascularDaiichi SankyoedoxabanPharmaceuticalResearchWarfarin Sodium

1 to 25 of 146 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top